As of 2025-06-17, the Fair Value of ANI Pharmaceuticals Inc (ANIP) is -0.66 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 64.29 USD, the upside of ANI Pharmaceuticals Inc is -101.02%.
With the market price of 64.29 USD and our fair value calculation, ANI Pharmaceuticals Inc (ANIP) is not a good investment. Investing in ANIP stocks now will result in a potential loss of 101.02%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -22.50 | -42.60 | -47.90 | 18.78 | -18.52 | -22.55 |
| YoY growth | -468.85% | -89.33% | -12.44% | 139.20% | -198.63% | -126.01% |
| Market Cap (mil) | 1,391.88 |
| P/E | |
| Forward P/E |
| EPS | -0.13 |
| Avg earnings growth rate | -126.01% |
| TTM earnings | -2.84 |